Gemini Pharmaceuticals earns GRMA lab recognition and Amazon Fast-Track eligibility
Gemini Pharmaceuticals became the first organization to hold both GRMA GMP manufacturer certification and GRMA-recognized laboratory status with an ISO 17025 scope extension. The milestone gives Gemini eligibility for Amazon’s Dietary Supplement Compliance Fast-Track program and could speed compliance, listings, and time to market for brand partners.
Why it matters: - Gemini Pharmaceuticals now has a dual GRMA distinction that links manufacturing and laboratory quality under one compliance pathway. - The recognition makes Gemini eligible for Amazon’s Dietary Supplement Compliance Fast-Track program, which can reduce paperwork and help brands keep products listed. - The development may help dietary supplement brands launch faster if they use Gemini for manufacturing and testing.
What happened: - The Global Retailer and Manufacturer Alliance announced that Gemini Pharmaceuticals’ laboratory earned recognition under the GRMA Dietary Supplement Product Integrity Program. - The recognition extends Gemini’s ISO 17025 accreditation scope. - Gemini is now eligible to participate in Amazon’s Compliance Fast-Track program for dietary supplements. - Gemini is the first organization in the industry to hold both GRMA GMP-certified manufacturer status and GRMA-recognized laboratory status with a GRMA ISO 17025 accreditation scope extension. - The announcement was issued from King of Prussia, Pennsylvania, on June 11, 2026.
The details: - Amazon’s Compliance Fast-Track program is designed to give dietary supplement brands a more streamlined way to meet Amazon safety requirements. - GRMA says organizations with products manufactured at GRMA GMP-certified facilities and tested by GRMA-recognized laboratories can gain three advantages. - Those advantages are simplified documentation, uninterrupted selling, and faster time to market. - Simplified documentation means brands do not need to manage and submit complex compliance materials for each product. - Uninterrupted selling means products can maintain listing status without compliance-related interruptions. - Faster time to market means new products can be listed sooner. - GRMA awards laboratory recognition after a lab demonstrates conformance across five areas: test methods, environment, equipment, personnel, and data management. - Gemini is authorized to provide GRMA ReportLOQ Product Certificates of Analysis to support brand partners and retailer requirements. - Gemini operates FDA and Health Canada registered facilities. - Gemini’s on-site laboratory holds ISO 17025 accreditation. - Gemini’s services include capsule manufacturing, tablet manufacturing, blending operations, functional tablet coating, packaging operations, stability testing, product development, and analytical testing. - Gemini says it combines high-speed automated packaging lines with environmentally conscious manufacturing practices.
Between the lines: - The recognition gives GRMA a concrete example of the kind of manufacturer-lab combination it wants to reward: verified manufacturing quality plus lab rigor. - For Amazon-facing brands, the practical value is less about the accreditation language and more about reducing friction in compliance reviews. - The milestone also signals that laboratory credibility is becoming a bigger commercial differentiator in dietary supplements, not just a technical one.
What’s next: - Gemini is positioned to market the new recognition to brand partners that sell on Amazon or need retailer-facing compliance support. - GRMA’s Product Integrity Program is likely to remain a reference point for brands and retailers looking for verified supply-chain confidence. - Gemini and GRMA both point to broader industry use of the program as the next step.
The bottom line: - Gemini’s dual GRMA recognition ties lab quality and manufacturing quality to a more direct path for Amazon compliance, which could make the company more attractive to supplement brands looking to scale faster.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Manufacturing Press Releases
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.